0001425738-13-000004.txt : 20130214 0001425738-13-000004.hdr.sgml : 20130214 20130214163956 ACCESSION NUMBER: 0001425738-13-000004 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121231 FILED AS OF DATE: 20130214 DATE AS OF CHANGE: 20130214 EFFECTIVENESS DATE: 20130214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Redmile Group, LLC CENTRAL INDEX KEY: 0001425738 IRS NUMBER: 208592298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12776 FILM NUMBER: 13614906 BUSINESS ADDRESS: STREET 1: ONE LETTERMAN DRIVE STREET 2: BUILDING D, SUITE D3-700 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 BUSINESS PHONE: 415-489-9980 MAIL ADDRESS: STREET 1: ONE LETTERMAN DRIVE STREET 2: BUILDING D, SUITE D3-700 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 13F-HR 1 red4q2012report.2.txt 4Q2012 13F-HR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2012 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Redmile Group LLC Address: One Letterman Drive Building D, Suite D3-700 San Francisco, CA 94129 13F File Number: 028-12776 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Jeremy Green Title: Managing Member Phone: 415-489-9980 Signature, Place, and Date of Signing: /s/ Jeremy Green San Francisco, CA February 14, 2013 Report Type (Check only one.): [ X] 13F HOLDINGS REPORT. [ ] 13F NOTICE. [ ] 13F COMBINATION REPORT. FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 40 Form 13F Information Table Value Total: $345,133 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional managers with respect to which this report is filed, other than the manager filing this report. NONE FORM 13F INFORMATION TABLE VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE ------------------------------ ---------------- --------- -------- -------- --- ---- ------- ------------ -------- -------- -------- ACCURAY INC NOTE 3.750% 8/0 004397AB1 503 500000 ALIGN TECHNOLOGY INC COM 016255101 1610 580150 AMICUS THERAPEUTICS INC COM 03152W109 3006 1121700 ANTHERA PHARMACEUTICALS INC COM 03674U102 1111 1791800 ARIAD PHARMACEUTICALS INC COM 04033A100 21045 1097242 ARRAY BIOPHARMA INC COM 04269X105 16281 4376520 ARTHROCARE CORP COM 043136100 8993 260000 BIOSPECIFICS TECHNOLOGIES CO COM 090931106 4667 312152 CARDINAL HEALTH INC COM 14149Y108 18727 454750 CLOVIS ONCOLOGY INC COM 189464100 5649 353077 CONCEPTUS INC COM 206016107 11292 537472 CUTERA INC COM 232109108 3055 339457 CYCLACEL PHARMACEUTICALS INC COM NEW 23254L306 3791 672680 DYNAVAX TECHNOLOGIES CORP COM 268158102 15583 5448497 EXELIXIS INC COM 30161Q104 6278 1373654 EXELIXIS INC NOTE 4.250% 8/1 30161QAC8 4891 5000000 EXPRESS SCRIPTS HLDG CO COM 30219G108 16257 301050 GILEAD SCIENCES INC COM 375558103 21093 287170 GRIFOLS S A SP ADR REP B NVT 398438408 12559 484353 HCA HOLDINGS INC COM 40412C101 7995 265000 HEALTH MGMT ASSOC INC NEW CL A 421933102 192 20600 HEARTWARE INTL INC COM 422368100 19411 231226 IDENIX PHARMACEUTICALS INC COM 45166R204 146 30200 KYTHERA BIOPHARMACEUTICALS I COM 501570105 3344 110218 MEDIVATION INC COM 58501N101 10650 208172 MOMENTA PHARMACEUTICALS INC COM 60877T100 158 13400 NEUROCRINE BIOSCIENCES INC COM 64125C109 6045 808100 ONYX PHARMACEUTICALS INC COM 683399109 33316 441101 OPTIMER PHARMACEUTICALS INC COM 68401H104 4697 519000 OREXIGEN THERAPEUTICS INC COM 686164104 6531 1239240 PUMA BIOTECHNOLOGY INC COM 74587V107 8148 434570 SALIX PHARMACEUTICALS INC COM 795435106 18244 450700 SEQUENOM INC COM NEW 817337405 12605 2670518 STRYKER CORP COM 863667101 21785 397400 TESARO INC COM 881569107 1646 97109 TRANS1 INC COM 89385X105 2063 831963 TRIUS THERAPEUTICS INC COM 89685K100 3179 665067 UNITEDHEALTH GROUP INC COM 91324P102 271 5000 UNIVERSAL HLTH SVCS INC CL B 913903100 5560 115000 VANGUARD HEALTH SYS INC COM 922036207 2756 225000